Hypoxia stimulates p16 expression and association with cdk4

被引:20
|
作者
Zygmunt, A [1 ]
Tedesco, VC [1 ]
Udho, E [1 ]
Krucher, NA [1 ]
机构
[1] Pace Univ, Dept Biol Sci, Pleasantville, NY 10570 USA
关键词
hypoxia; p16; cdk4; pRb;
D O I
10.1006/excr.2002.5564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Exposure of CV-1P cells to hypoxic conditions causes cell proliferation inhibition concomitant with the accumulation of pRb in the hypophosphorylated, growth suppressive form. This is in part due to inhibition of pRb-directed cdk4 and cdk2 activity. In this study we attempted to elucidate the mechanism by which cdk4 is inactivated under hypoxic conditions. After 18 h of hypoxia, CV-1P cells are inhibited from progressing from G, phase into the S phase of the cell cycle. This occurs in conjunction with dephosphorylation of serine-795, which is a putative substrate of cdk4. The amounts of cdk4, cdk6, and the D type cyclins are not affected by 18 h of hypoxia. The levels of cdki p16, p18, p19, and p57 under aerobic or hypoxic conditions were analyzed and although the levels of most cdki are unaffected by hypoxic conditions, the level of p16 increases significantly by 18 h of hypoxia. The mechanism by which cdk4 activity is inhibited under hypoxic conditions may be mediated through p16 association with cdk4. Immunoprecipitation analysis shows that p16 binds to cdk4 under hypoxic conditions but does not in cells maintained under aerobic conditions. Thus p16 may be involved in hypoxia-induced growth inhibition. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:53 / 60
页数:8
相关论文
共 50 条
  • [21] Analysis of P16, CDK4 and PTEN immunoexpression in oral melanocytic nevi and melanomas
    Santana, T.
    Queiroz, A.
    Trierveiler, M.
    VIRCHOWS ARCHIV, 2020, 477 : S321 - S322
  • [22] Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy
    Poomsawat, Sopee
    Buajeeb, Waranun
    Khovidhunkit, Siribang-on Piboonniyom
    Punyasingh, Jirapa
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (04) : 294 - 299
  • [23] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma.
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    LABORATORY INVESTIGATION, 1998, 78 (01) : 13A - 13A
  • [24] Immunohistochemical analysis of the expression of cdk4 and p16(INK4) in human endometrioid-type endometrial carcinoma
    Shiozawa, T
    Nikaido, T
    Shimizu, M
    Zhai, YL
    Fujii, S
    CANCER, 1997, 80 (12) : 2250 - 2256
  • [25] Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma
    Zuo, L
    Weger, J
    Yang, QB
    Goldstein, AM
    Tucker, MA
    Walker, GJ
    Hayward, N
    Dracopoli, NC
    NATURE GENETICS, 1996, 12 (01) : 97 - 99
  • [26] Immunohistochemical detection of CDK4 and p16(INK4) proteins in cutaneous malignant melanoma
    Wang, YL
    Uhara, H
    Yamazaki, Y
    Nikaido, T
    Saida, T
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (02) : 269 - 275
  • [27] P16(INK4) - AN SPECIFIC INHIBITOR OF THE CDK4/CYCLIN-D KINASE
    BEACH, D
    SERRANO, M
    HANNON, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 207 - 207
  • [28] P16(INK4) - AN SPECIFIC INHIBITOR OF THE CDK4/CYCLIN-D KINASE
    BEACH, D
    SERRANO, M
    HANNON, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 161 - 161
  • [29] Several noncontiguous domains of CDK4 are involved in binding to the p16 tumor suppressor protein
    Ceha, HM
    Nasser, I
    Medema, RH
    Slebos, RJC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 550 - 555
  • [30] CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component
    Xu, Guiyan
    Li, Jian Yi
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (03) : 445 - 452